The beneficial impact of metabolic dysfunction associated with fatty liver disease in patients with non-viral hepatocellular carcinoma treated with lenvatinib: an international study

HEPATOLOGY(2022)

引用 5|浏览3
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要